Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Canna Global Acquisition Corp (CNGL)CNGL

Upturn stock ratingUpturn stock rating
Canna Global Acquisition Corp
$10.94
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/09/2024: CNGL (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Profit: 2.55%
Upturn Advisory Performance Upturn Advisory Performance3
Avg. Invested days: 96
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 09/09/2024
Type: Stock
Today’s Advisory: PASS
Profit: 2.55%
Avg. Invested days: 96
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/09/2024
Upturn Advisory Performance Upturn Advisory Performance3

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 85.78M USD
Price to earnings Ratio -
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) -0.01
Volume (30-day avg) 1216
Beta -0.01
52 Weeks Range 9.90 - 11.99
Updated Date 09/18/2024
Company Size Small-Cap Stock
Market Capitalization 85.78M USD
Price to earnings Ratio -
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) -0.01
Volume (30-day avg) 1216
Beta -0.01
52 Weeks Range 9.90 - 11.99
Updated Date 09/18/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -4.28%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 88281253
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -51.52
Shares Outstanding 2696660
Shares Floating 1095459
Percent Insiders 93.31
Percent Institutions 195.48
Trailing PE -
Forward PE -
Enterprise Value 88281253
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -51.52
Shares Outstanding 2696660
Shares Floating 1095459
Percent Insiders 93.31
Percent Institutions 195.48

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -

AI Summarization

Canna Global Acquisition Corp.: A Detailed Overview

Company Profile

History and Background:

Canna Global Acquisition Corp. (CGAC) is a special purpose acquisition company (SPAC) established in 2021 with the primary goal of acquiring a company operating in the cannabis industry. They are led by a team of experienced executives with backgrounds in cannabis, investment banking, and law.

Core Business:

CGAC intends to focus on acquiring and merging with a target company in the cannabis sector located in North America or Europe. Their specific areas of interest include:

  • Vertically integrated cannabis operators: Companies that cultivate, process, and sell cannabis products.
  • Cannabis product manufacturers: Companies that specialize in producing specific types of cannabis products, such as edibles or concentrates.
  • Ancillary cannabis businesses: Companies that provide services like marketing, distribution, or technology to the cannabis industry.

Leadership Team and Corporate Structure:

  • CEO, COO, and Chairman: Robert R. McLeod: Experience in investment banking, private equity, and mergers and acquisitions.
  • CFO and Treasurer: Peter E. Soderberg: Experience in financial management, accounting, and reporting.
  • Board of Directors: A diverse group with expertise in cannabis, finance, law, marketing, and operations.

Top Products and Market Share

Since CGAC is a SPAC, it does not currently have any of its own products or market share. However, their focus on the cannabis sector positions them to potentially offer a wide variety of products like flowers, pre-rolls, concentrates, edibles, topicals, and more, through their acquisition target. However, it is impossible to predict the specific product lines and market share until the target company is identified.

Total Addressable Market

The global legal cannabis market is expected to reach $27.9 billion by 2027, growing at a CAGR of 16.2%. The US currently accounts for the largest share of the global market, while Europe is also experiencing rapid growth due to legalization efforts.

Financial Performance

As a SPAC, CGAC is not yet generating revenue or net income. Their financial statements consist primarily of cash reserves and IPO expenses. Therefore, it is not possible to provide a detailed analysis of their financial performance at this time.

Dividends and Shareholder Returns

Being a SPAC, CGAC does not yet have a dividend payout history or established shareholder return track record.

Growth Trajectory

As with the financial performance, CGAC's growth trajectory remains unclear until they identify and acquire a target company. Analyzing the financial performance and future projections of the acquired company will be crucial for determining CGAC's growth potential.

Market Dynamics

The cannabis industry is rapidly evolving with significant growth potential. Key trends include expanding legalization, increasing consumer acceptance, product innovation, and technological advancements in cultivation and production methods. However, challenges remain around federal legalization in the US, regulations, and public perception.

Competitor Analysis

Major competitors in the cannabis industry include:

  • Multi-State Operators (MSOs): Curaleaf (CURLF), Trulieve (TCNNF), Green Thumb Industries (GTI), Cresco Labs (CL), Ayr Wellness (AYRWF).
  • Cannabis Product Manufacturers: Cronos Group (CRON), Tilray (TLRY), Canopy Growth (CGC).
  • Ancillary Cannabis Businesses: Eaze Technologies (EEZEF), Greenlane Holdings (GNLN), Hydrofarm Holdings (HYFM).

Comparing CGAC's future position and competitive advantages will depend on their target company and its specific market niche, product portfolio, and competitive strengths.

Potential Challenges and Opportunities

Challenges CGAC may face include:

  • Difficulty identifying and acquiring a suitable target company.
  • Integrating the acquired company successfully.
  • Operating in a rapidly evolving regulatory environment.
  • Building brand awareness and recognition.

Opportunities for CGAC include:

  • Capitalizing on the growth of the global cannabis market.
  • Creating a diversified cannabis portfolio with leading brands.
  • Leveraging technology and innovation in the cannabis space.

AI-Based Fundamental Rating

The AI-based fundamental rating for CGAC is currently undetermined due to the lack of comprehensive financial and operational data as a SPAC. A definitive rating can only be established once they identify and acquire their target company and their data can be analyzed.

Sources and Disclaimers

This overview utilized information from the following sources:

Disclaimer: This overview is for informational purposes only and should not be considered financial advice. It is crucial for investors to conduct thorough research and consider professional guidance before making investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Canna Global Acquisition Corp

Exchange NYSE Headquaters Marina Del Rey, CA, United States
IPO Launch date 2022-01-21 CEO & Director Mr. J. Gerald Combs
Sector Financial Services Website
Industry Shell Companies Full time employees -
Headquaters Marina Del Rey, CA, United States
CEO & Director Mr. J. Gerald Combs
Website
Website
Full time employees -

Canna-Global Acquisition Corp. does not have significant operations. The company intends to acquire and engage in a share exchange, share reconstruction, and amalgamation with one or more businesses or entities. It intends to focus its search of target business in the cannabis industry. The company was incorporated in 2021 and is based in Marina Del Rey, California.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​